Levetiracetam: all 205 studies that test it
Page 2 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status EpilepticusCompletedNCT07052136Not applicable
- Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older AdultsActive, not recruitingNCT06919926Phase 2
- The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status EpilepticusCompletedNCT06403150Phase 4
- Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,FaisalabadCompletedNCT06067412Not applicable
- Clinical Trial of AGB101 for Mild Cognitive ImpairmentWithdrawnNCT05986721Phase 2
- Intermittent Levetricetam in Treatment of Febrile ConvulsionsStatus unknownNCT05860153Not applicable
- Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related PsychosisActive, not recruitingNCT05824728Phase 2
- Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in ChildrenCompletedNCT04926844Phase 2
- Post-stroke Epilepsy: Primary Prophylaxis StudyStatus unknownNCT04858841Not applicable
- Changing Agendas on Sleep, Treatment and Learning in EpilepsyTerminatedNCT04610879Phase 4
- R33: Levetiracetam in Early PsychosisCompletedNCT04317807Phase 2
- Levetiracetam Versus Phenytoin in Management of Pediatric Status EpilepticusStatus unknownNCT04176887Phase 4
- Treating Hyperexcitability in AD With LevetiracetamCompletedNCT03875638Phase 2
- An Investigation of Levetiracetam in Alzheimer's DiseaseCompletedNCT03489044Phase 2
- Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEGStatus unknownNCT03107507Phase 4
- Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?Status unknownNCT03054285Phase 4
- Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status EpilepticusCompletedNCT02920060Phase 2
- Validation of the Role of Levetiracetam for Newly Diagnosed GBM PatientsStatus unknownNCT02815410Phase 2
- Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status EpilepticusWithdrawnNCT02726867Phase 3
- A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy VolunteersCompletedNCT02602860Phase 1
- Levetiracetam Treatment of Neonatal SeizuresTerminatedNCT02550028Phase 1/2
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II StudyCompletedNCT02229123Phase 2
- The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled StudyCompletedNCT02208492Phase 4
- A Relative Bioavailability Study of Fluticasone Furoate and LevocabastineCompletedNCT01962467Phase 1
- Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot StudyWithdrawnNCT01935908Phase 4
- Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy MalesCompletedNCT01725009Phase 1
- An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in ChineseCompletedNCT01618903Phase 1
- A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy VolunteersCompletedNCT01618877Phase 1
- Imaging the Effect of Centrotemporal Spikes and Seizures on Language in ChildrenCompletedNCT01521130Phase 1
- Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese SubjectsCompletedNCT01394224Phase 1
- Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationCompletedNCT01392768Phase 3
- Study of Antiepileptic Drug in Generalised Convulsive Status EpilepticusCompletedNCT01150331Phase 3
- Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01132352Phase 1
- Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.CompletedNCT01131897Phase 1
- Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)CompletedNCT00985348Phase 1
- A Bioequivalence Study of Levetiracetam Versus KeppraCompletedNCT00926302Not applicable
- Bioequivalency Study of Levetiracetam 1g Tablets Under Fed ConditionsCompletedNCT00827320Not applicable
- Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting ConditionsCompletedNCT00826865Not applicable
- Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed ConditionsCompletedNCT00826787Not applicable
- Bioequivalency Study of Levetiracetam 1g Under Fasted ConditionsCompletedNCT00826722Not applicable
- Keppra for Cervical DystoniaTerminatedNCT00760318Phase 2
- Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent PatientsCompletedNCT00758277Phase 3
- Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00643500Phase 4
- A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00631150Phase 4
- S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00630968Phase 4
- Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial EpilepsyCompletedNCT00630630Phase 4
- Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial EpilepsyCompletedNCT00630357Phase 4
- Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsCompletedNCT00629889Phase 2
- Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot StudyWithdrawnNCT00627133Phase 2
- Efficacy of Levetiracetam in Essential TremorCompletedNCT00620165Phase 1/2
- Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset SeizuresCompletedNCT00615615Phase 3
- Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)CompletedNCT00612859Phase 2
- Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset SeizuresCompletedNCT00610454Phase 2
- Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind MethodCompletedNCT00600509Phase 2
- Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.CompletedNCT00593125Phase 2
- Keppra IV for the Treatment of Motor Fluctuations in Parkinson's DiseaseWithdrawnNCT00584025Phase 4
- Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo SurgeryCompletedNCT00571155Phase 4
- Prevention of Post-traumatic Seizures With LevetiracetamTerminatedNCT00566046Phase 3
- A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence SeizuresCompletedNCT00545012Phase 2
- Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years OldCompletedNCT00544050Phase 2
- Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset CrisisStatus unknownNCT00542802Phase 3
- Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)CompletedNCT00518570Not applicable
- Seizure Therapy With Intravenous Levetiracetam and LorazepamWithdrawnNCT00465244Phase 2/3
- Levetiracetam in Central Pain in Multiple Sclerosis(MS)CompletedNCT00423527Phase 4
- Levetiracetam in Treating Patients With Seizures Caused by Brain MetastasesWithdrawnNCT00415376Not applicable
- Levetiracetam in Post-Traumatic Stress DisorderCompletedNCT00413296Phase 2/3
- Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)Status unknownNCT00393614Phase 4
- Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)TerminatedNCT00376766Phase 3
- Safety and Tolerability Study of Levetiracetam to Treat Patients With Status EpilepticusStatus unknownNCT00362141Phase 2
- A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence EpilepsyCompletedNCT00361010Not applicable
- The Effects of Levetiracetam on Alcohol Dependent SubjectsCompletedNCT00325182Phase 4
- Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron DiseaseCompletedNCT00324454Phase 2
- Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's DiseaseCompletedNCT00307450Phase 4
- Augmentation Study of Levetiracetam in Obsessive Compulsive DisorderTerminatedNCT00299611Phase 2/3
- Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's DiseaseStatus unknownNCT00291733Phase 2
- Levetiracetam Treatment of Tardive DyskinesiaCompletedNCT00291213Phase 3
- Levetiracetam for Painful PolyneuropathyCompletedNCT00286260Phase 4
- A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00280696Phase 3
- Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic AttacksCompletedNCT00279617Phase 3
- The Effect of Levetiracetam on the Postmastectomy Pain SyndromeCompletedNCT00262262Not applicable
- Levetiracetam for Treatment of Pain Associated With FibromyalgiaCompletedNCT00254657Not applicable
- A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)CompletedNCT00247364Phase 2
- Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.CompletedNCT00245713Phase 4
- Lamotrigine Versus Levetiracetam in the Initial Monotherapy of EpilepsyCompletedNCT00242606Phase 3
- Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.Status unknownNCT00227461Phase 1
- Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept StudyCompletedNCT00223223Phase 4
- Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy VolunteersCompletedNCT00221988Not applicable
- Levetiracetam for Benign Rolandic EpilepsyCompletedNCT00181116Phase 4
- Levetiracetam in the Treatment of Neuroleptic-induced Tardive DyskinesiaCompletedNCT00175955Phase 2
- Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed EpilepsyCompletedNCT00175903Phase 3
- A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.CompletedNCT00175890Phase 3
- Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With EpilepsyCompletedNCT00160628Phase 3
- Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome DyskinesiasCompletedNCT00160576Phase 2
- Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic SeizuresCompletedNCT00160550Phase 3
- A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)CompletedNCT00160511Phase 2
- A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.CompletedNCT00156689Phase 2
- Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POSCompletedNCT00152373Phase 3
- Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.CompletedNCT00150787Phase 3
- Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + AdultsCompletedNCT00150774Phase 3